Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

80
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/26/2015 03/27/2015 03/30/2015 03/31/2015 04/01/2015 Date
57.27(c) 57.65(c) 58.24(c) 58.54(c) 57.1(c) Last
10 853 908 6 830 106 5 781 909 12 313 641 14 903 269 Volume
-1.63% +0.66% +1.02% +0.52% -2.46% Change
More quotes
Financials ($)
Sales 2015 22 478 M
EBIT 2015 8 981 M
Net income 2015 6 970 M
Debt 2015 3 500 M
Yield 2015 3,43%
Sales 2016 24 364 M
EBIT 2016 10 184 M
Net income 2016 7 637 M
Debt 2016 790 M
Yield 2016 3,80%
PER 2015 14,29
PER 2016 11,84
EV / Sales 2015 4,28x
EV / Sales 2016 3,84x
Capitalization 92 727 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
04/13Ex-dividend day
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
04/01 ABBVIE : CF Scholarship Application for Students with Cystic Fibrosis Now Availa..
04/01 ABBVIE : Patent Issued for Solid Compositions
04/01 ABBVIE : HUMIRA® (Adalimumab) Approved by European Commission to Treat Children ..
04/01M&A : The deals strengthen in the first quarter of 2015
03/31DJVital Signs Show the Market for Health-Deals Is In the Pink
03/30 UnitedHealth-Catamaran deal sets up healthcare M&A chessboard
03/30 ABBVIE : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
03/28 ABBVIE : Galapagos raises EU5.8 million through warrant exercises, Board and Exe..
More news
Sector news : Biopharmaceuticals
04/01 VALEANT PHARMACEUTICALS INTL : BRIEF: Valeant completes Salix acquisition
04/01 VALEANT PHARMACEUTICALS INTL : Salix Provides Notice of Fundamental Changes, Mak..
04/01 VALEANT PHARMACEUTICALS INTL : Salix Provides Notice of Fundamental Changes, Mak..
More sector news : Biopharmaceuticals
4-Traders Strategies on ABBVIE INC 
02/13A likely recovery
More Strategies
News from SeekingAlpha
04/01 10 Top Dividend Healthcare Dogs Declare 5% To 20% March Upsides
04/01 A Pre-Earnings Update On Gilead
03/31 AMERISOURCEBERGEN : A Great Growth Story
03/31 Infinity Pharma buys out royalty obligations from Takeda for $52.5M
03/30 Nonfarm Payrolls Will Be Closely Watched - Cramer's Mad Money (3/27/15)


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF